|  | Conditions & Treatments | Migraine

DHE for Migraine: Uses, Administration, and Safety Guide

Introduction

Dihydroergotamine (DHE) was first approved for migraine treatment in 1946. Although newer drugs such as triptans have become first‑line therapy, DHE remains a valuable option when other medications fail, despite its higher cost.

Available Forms

DHE can be administered in three ways:

  • Nasal spray (brand names Migranal and Trudhesa)
  • Subcutaneous injection (home‑use)
  • Intravenous (IV) infusion (hospital or infusion center)

Who Might Benefit

DHE is typically considered for patients who have not achieved relief with first‑line treatments such as triptans. It can be especially helpful for:

  • Severe or refractory migraine attacks
  • Patients who cannot tolerate triptans

Contraindications

Do not use DHE if you are:

  • Pregnant
  • Diagnosed with cardiovascular disease

Avoid DHE when you are taking any of the following:

  • Macrolide antibiotics (e.g., erythromycin)
  • Protease inhibitors (HIV medications)
  • Another ergot alkaloid or migraine drug within the previous 24 hours

Administration Settings

IV infusion is usually performed in a hospital, emergency department, or outpatient infusion center. The exact dosing protocol varies by facility and patient needs. Some patients stay overnight; others attend several consecutive hourly sessions.

Both IV infusion and home subcutaneous injection deliver the same bioavailability, meaning the body receives an equivalent amount of drug. However, only the IV route requires a trained medical team.

How to Give a Subcutaneous Injection

A healthcare professional should train you on the technique. The injection is given under the skin, not into a muscle.

  1. Inspect the ampule – it must be intact, and the liquid clear.
  2. Disinfect the ampule top with an alcohol swab and break the seal.
  3. Tilt the ampule 45° and draw the prescribed dose into a sterile syringe.
  4. Remove any air bubbles.
  5. Disinfect the injection site (mid‑thigh, above the knee) with a fresh alcohol swab.
  6. Pinch a 1‑inch fold of skin.
  7. Insert the needle into the skin fold.
  8. Pull back on the plunger slightly to confirm no blood return.
  9. Depress the plunger to inject the medication.
  10. Withdraw the needle and clean the site with another alcohol swab.

Nasal Spray Options

The nasal sprays are intended for acute migraine attacks only; they are not preventive treatments.

Migranal

Bioavailability ≈ 32 % (lower than injection). Use two sprays 15 minutes apart for a single dose.

  1. Attach the pump to the vial as directed.
  2. Prime the device by pumping four times.
  3. Hold the vial upright, aim away from your face, and spray once into each nostril with the head tilted forward. Do not sniff.
  4. Wait 15 minutes.
  5. Repeat the spray into each nostril.
  6. Dispose of the vial; remaining medication cannot be saved.

Trudhesa

One spray per nostril constitutes a full dose. A second dose may be taken from a new vial at least one hour later if needed.

  1. Assemble and prime the sprayer (four pumps).
  2. Spray once into each nostril.

Both products should not exceed four sprays in 24 hours or six sprays in a seven‑day period.

Side Effects

Common, mild side effects include nausea, fatigue, dizziness, and injection‑site irritation. Severe reactions that require immediate medical attention may involve chest pain, severe hypertension, sudden shortness of breath, or allergic symptoms such as swelling or rash.

When to Contact a Doctor

If you experience any severe side effect, or if mild symptoms persist or worsen, seek medical care promptly.

How DHE Works

DHE contracts dilated blood vessels and dampens inflammatory pathways, providing relief from migraine pain. It also interacts with serotonin, norepinephrine, and dopamine receptors.

DHE’s Place in Migraine Therapy

DHE is a second‑ or third‑line option. Typical first‑line agents are:

  • Acetaminophen (Tylenol) and over‑the‑counter NSAIDs (ibuprofen, naproxen)
  • Prescription triptans for moderate to severe attacks

When triptans are ineffective or contraindicated, clinicians may add antiemetics (e.g., metoclopramide, prochlorperazine) and consider DHE—preferably via injection or IV for refractory cases.

Bottom Line

If your current migraine regimen isn’t providing relief, discuss DHE with your doctor. It can be an effective rescue therapy, especially when administered by injection or IV, but it requires careful screening for contraindications and close monitoring for side effects.


Migraine - Related Articles